Results 301 to 310 of about 504,834 (381)

Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis

open access: yesArthritis &Rheumatology, EarlyView.
Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley   +1 more source

Jejunal diverticulosis: complications and management - a case series. [PDF]

open access: yesJ Surg Case Rep
Betz E   +4 more
europepmc   +1 more source

A randomized, double‐blind, placebo‐controlled trial of abatacept for the treatment of relapsing, non‐severe, granulomatosis with polyangiitis

open access: yesArthritis &Rheumatology, Accepted Article.
Objective To compare the efficacy of abatacept to placebo for the treatment of relapsing, non‐severe granulomatosis with polyangiitis (GPA). Methods In this multicenter trial, eligible patients with relapsing, non‐severe GPA were randomized to receive abatacept 125 mg subcutaneously once a week or placebo, both together with prednisone 30 mg/day (or ...
Carol A. Langford   +30 more
wiley   +1 more source

3D printing variation: Teaching and assessing hepatobiliary variants in human anatomy

open access: yesAnatomical Sciences Education, EarlyView.
Abstract Textbook anatomy depiction of the hepatobiliary tree is present in 55%–62% of the population. Misidentification of hepatobiliary variants can lead to bile duct injuries in cholecystectomies. A better understanding of variants has been cited as a key area for improvement in anatomy education.
Christian Myles   +2 more
wiley   +1 more source

Senkyunolide I Improves Septicemia‐Induced Brain Dysfunction via Regulating Nrf2 and Astrocyte Activity.

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Senkyunolide I (Sen I) has a protective effect on the blood–brain barrier (BBB) in rats with sepsis‐associated encephalopathy (SAE). This study investigated whether Sen I regulates Nrf2 to ameliorate sepsis‐induced brain dysfunction (SIBD). Sixty rats were randomly assigned into Sham group, SAE group (Model group), SAE + Sen I group (72 mg/kg,
Haohao Cao, Tao Liu, Meixia Xu
wiley   +1 more source

Bovine Pericardium Graft as a Salvage Option in Septoplasties at Risk of Septal Perforation. [PDF]

open access: yesJ Clin Med
Sánchez Barrueco A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy